Head-to-head
CoreAge Rx vs Eve
CoreAge Rx and Eve both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxEve
Ranked #28 · Grade C
Best for: Working moms who want one flat price no matter which molecule or delivery form they pick, and who are comfortable confirming state coverage during signup rather than before.
Visit EveThe verdict
CoreAge Rx edges out Eve on the Rx-Readiness Score, 95 to 69 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Eve is still a genuine option — one flat $195/mo plan covers compounded semaglutide, compounded tirzepatide, or a needle-free sublingual option — plus real brand-name access if you want an FDA-approved pen instead — with a women's-health-first framing and a $99 first month, though it won't name your state until you're inside the signup flow. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Eve |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 69/100 · C |
| Overall rank | #1 | #28 |
| Semaglutide | $99/mo | $195/mo |
| Tirzepatide | $149/mo | $195/mo |
| Coverage | All 50 states | Multiple states (not fully enumerated — confirm yours before signing up) |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Eve
Ranked #28 · Grade C
What we like
- One flat $195/mo price whether you pick semaglutide, tirzepatide, or the sublingual/oral form — no separate pricing tier to compare
- You aren't charged unless a licensed physician actually approves you, stated plainly on the pricing page
- Free shipping on orders over $50, and a LegitScript seal (ID 42862417) you can verify independently
The caveats
- Full standing pricing is gated behind the go.tryeve.co signup flow — the public site only shows the $0/$99 promo fragment, not the $195/mo rate, up front
- States served aren't enumerated anywhere; confirm yours before you start
- Named pharmacy partner, 503A/503B designation, and medical director are not disclosed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Eve against other providers on our shortlist.
Or browse the full comparison hub.